China Biotech 2026: America Against America(Part 1)
Time：
2026-08-28 17:15
Author：
Morgan Xu, PhD
Nearly $500,000 per cancer vaccine shot? When mRNA starts to add up.
Time：
2026-08-28 08:52
Author：
xieyijun
When "the first year of domestic innovation" meets the change in Washington
From "Is there" to "Is it good"
Time：
2026-08-27 08:07
Author：
xieyijun
The A and B sides of tumor vaccine development: A calm examination by an immunologist
"Let the bullets fly a bit longer"
Time：
2026-08-26 08:11
Author：
xieyijun
Time：
2026-08-25 08:04
Author：
xieyijun
Exclusive Interview with Xiao Xiao | Why Belief Medicine Broke Up with Takeda
Faith Pharmaceuticals is still trying.
Time：
2026-08-24 08:04
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务